Cuprina Holdings Announces Closing of Underwriter’s Over-Allotment Option in Connection with Initial Public Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 08 2025
0mins
Source: Globenewswire
Company Overview: Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company based in Singapore, focuses on developing products for chronic wounds, infertility, and cosmeceuticals. They recently completed the sale of 450,000 Class A ordinary shares at $4.00 each, raising a total of $13.8 million through their IPO.
Legal and Regulatory Information: The offering was managed by R. F. Lafferty & Co., Inc., with legal counsel from various firms across the U.S., Singapore, and the Cayman Islands. Investors are advised to review the prospectus and related documents filed with the SEC before making investment decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
